0001415889-21-001674.txt : 20210329
0001415889-21-001674.hdr.sgml : 20210329
20210329161429
ACCESSION NUMBER: 0001415889-21-001674
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210325
FILED AS OF DATE: 20210329
DATE AS OF CHANGE: 20210329
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tarka Elizabeth Ann
CENTRAL INDEX KEY: 0001783037
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31918
FILM NUMBER: 21781840
MAIL ADDRESS:
STREET 1: 111 WAVERLY CIRCLE
CITY: PHOENIXVILLE
STATE: PA
ZIP: 19460
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IDERA PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000861838
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 043072298
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 505 EAGLEVIEW BOULEVARD
STREET 2: SUITE 212
CITY: EXTON
STATE: PA
ZIP: 19341
BUSINESS PHONE: 4843481600
MAIL ADDRESS:
STREET 1: 505 EAGLEVIEW BOULEVARD
STREET 2: SUITE 212
CITY: EXTON
STATE: PA
ZIP: 19341
FORMER COMPANY:
FORMER CONFORMED NAME: HYBRIDON INC
DATE OF NAME CHANGE: 19951211
4
1
form4-03292021_010319.xml
X0306
4
2021-03-25
0000861838
IDERA PHARMACEUTICALS, INC.
IDRA
0001783037
Tarka Elizabeth Ann
505 EAGLEVIEW BOULEVARD
SUITE 212
EXTON
PA
19341
false
true
false
false
CHIEF MEDICAL OFFICER
Common Stock
2021-03-25
4
S
0
5018
1.3507
D
13237
D
Restricted Stock Units ("RSUs") granted to Reporting Person on January 10, 2020 were accelerated and became fully vested on March 23,
2021. The amount reported in Column 4 represents the number of shares of Issuer common stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 15,000 RSUs on March 23, 2021. This sale is mandated by the Issuer's election under its 2013 Stock Incentive Plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $1.3501 to $1.355 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ Elizabeth A. Tarka
2021-03-29